Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Companies count DNA sequences in the blood of high-risk moms to test for Down syndrome and other large-scale disruptions, but they could do more.
Amgen and Genzyme are pursuing disruptive ways of making biological drugs.
With new software, smartphones, and apps, the BlackBerry maker may still have a chance.
As well as making the grid more reliable and efficient, the technology could deliver high-speed Internet, TV, and telephony.